The host battles drug-Resistant tuberculosis

Science Translational Medicine

Volumn 6, Issue 263, 2014, Pages

  Maeurer, Markus ^a,b   Zumla, Alimuddin ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEDAQUILINE; CILOSTAZOL; CYCLOPHOSPHAMIDE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; DELAMANID; HISTONE DEACETYLASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 1; INTERLEUKIN 10; METFORMIN; PROGRAMMED DEATH 1 RECEPTOR; PROSTAGLANDIN E2; PYRAZINAMIDE; SILDENAFIL; TRANSFORMING GROWTH FACTOR BETA;

ANTIBIOTIC RESISTANCE; ARTICLE; AUTOPHAGY; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG RESISTANT TUBERCULOSIS; ENZYME ACTIVITY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTOSIS; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UNSPECIFIED SIDE EFFECT; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

HOST-PATHOGEN INTERACTIONS; HUMANS; METFORMIN; MYCOBACTERIUM TUBERCULOSIS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84911949856     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaa1274     Document Type: Article

References (10)

1. A. Singhal, L. Jie, P. Kumar, G. S. Hong, M. K.-S. Leow, B. Paleja, L. Tsenova, N. Kurepina, J. Chen, F. Zolezzi, B. Kreiswirth, M. Poidinger, C. Chee, G. Kaplan, Y. T. Wang, G. De Libero, Metformin as adjunct antituberculosis therapy. Sci. Transl. Med. 6, 263ra159 (2014).
2. A. I. Zumla, S. H. Gillespie, M. Hoelscher, P. P. Philips, S. T. Cole, I. Abubakar, T. D. McHugh, M. Schito, M. Maeurer, A. J. Nunn, New antituberculosis drugs, regimens, and adjunct therapies: Needs, advances, and future prospects. Lancet Infect. Dis. 14, 327-340 (2014).
3. S. H. Kaufmann, C. Lange, M. Rao, K. N. Balaji, M. Lotze, M. Schito, A. I. Zumla, M. Maeurer, Progress in tuberculosis vaccine development and host-directed therapies-A state of the art review. Lancet Respiratory Med. 2, 301-320 (2014).
4. R. S. Hotchkiss, L. L. Moldawer, Parallels between cancer and infectious disease. N. Engl. J. Med. 371, 380-383 (2014).
5. I. De Vlaminck, K. K. Khush, C. Strehl, B. Kohli, H. Luikart, N. F. Neff , J. Okamoto, T. M. Snyder, D. N. Cornfield, M. R. Nicolls, D. Weill, D. Bernstein, H. A. Valantine, S. R. Quake, Temporal response of the human virome to immunosuppression and antiviral therapy. Cell 155, 1178-1187 (2013).
6. K. D. Mayer-Barber, B. B. Andrade, S. D. Oland, E. P. Amaral, D. L. Barber, J. Gonzales, S. C. Derrick, R. Shi, N. P. Kumar, W. Wei, X. Yuan, G. Zhang, Y. Cai, S. Babu, M. Catalfamo, A. M. Salazar, L. E. Via, C. E. Barry 3rd, A. Sher, Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99-103 (2014).
7. J. J. Kim, H. M. Lee, D. M. Shin, W. Kim, J. M. Yuk, H. S. Jin, S. H. Lee, G. H. Cha, J. M. Kim, Z. W. Lee, S. J. Shin, H. Yoo, Y. K. Park, J. B. Park, J. Chung, T. Yoshimori, E. K. Jo, Host cell autophagy activated by antibiotics is required for their eff ective antimycobacterial drug action. Cell Host Microbe 11, 457-468 (2012).
8. M. Maiga, N. C. Ammerman, M. C. Maiga, A. Tounkara, S. Siddiqui, M. Polis, R. Murphy, W. R. Bishai, Adjuvant hostdirected therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment. J. Infect. Dis. 208, 512-519 (2013).
9. P. V. Licciardi, K. Ververis, M. L. Tang, A. El-Osta, T. C. Karagiannis, Immunomodulatory eff ects of histone deacetylase inhibitors. Curr. Mol. Med. 13, 640-647 (2013).
10. X. Liu, R. R. Chhipa, S. Pooya, M. Wortman, S. Yachyshin, L. M. Chow, A. Kumar, X. Zhou, Y. Sun, B. Quinn, C. McPherson, R. E. Warnick, A. Kendler, S. Giri, J. Poels, K. Norga, B. Viollet, G. A. Grabowski, B. Dasgupta, Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. Proc. Natl. Acad. Sci. U.S.A. 111, E435-E444 (2014).